(Q53293406)
Statements
Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -. (English)
Takuya Ozawa
Ken Toba
Hiroshi Suzuki
Kiminori Kato
Yoshitaka Iso
Yasushi Akutsu
Youichi Kobayashi
Youichi Takeyama
Naohiko Kobayashi
Norihiko Yoshimura
Kohei Akazawa
Yoshifusa Aizawa
EPO/AMI-I Pilot Study Researchers
22 May 2010
74
7
1415-1423